IRadimed Corporation (IRMD) Stock
IRadimed stock price chart
IRMD stock quote & key statistics
IRadimed annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $83.8M | $22.5M | $1.92 |
| FY2024 | $73.2M | $19.2M | $1.61 |
| FY2023 | $65.6M | $17.2M | $1.48 |
| FY2022 | $53.3M | $12.8M | $1.09 |
| FY2021 | $41.8M | $9.3M | $0.83 |
Fiscal year ending December 31. Source: company filings via EODHD.
About IRadimed Corporation
IRADIMED CORPORATION specializes in the development, manufacturing, marketing, and global distribution of medical devices that are compatible with magnetic resonance imaging (MRI) technology. Their comprehensive product lineup includes the MRidium MRI-compatible intravenous (IV) infusion pump system, complete with disposable IV tubing sets, alongside a range of MRI-compatible patient vital signs monitoring systems. In addition, the company offers non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors and accessories.
Catering primarily to hospitals, acute care facilities, and outpatient imaging centers, IRADIMED CORPORATION ensures its products meet stringent MRI safety standards, providing essential medical solutions for patients undergoing MRI procedures. Their distribution network encompasses direct sales through field representatives, regional sales directors, clinical support personnel, and partnerships with independent distributors, ensuring widespread availability and support for their innovative medical technologies.
Founded in 1992 and headquartered in Winter Springs, Florida, IRADIMED CORPORATION has established itself as a leader in MRI-compatible medical devices. With a commitment to advancing healthcare technology, the company continues to innovate and expand its product offerings, addressing critical needs in MRI environments globally.
Driven by a dedication to MRI safety and patient care, IRADIMED CORPORATION remains at the forefront of developing cutting-edge solutions that enhance medical imaging procedures and patient outcomes. Through ongoing research, strategic partnerships, and responsive customer support, the company reinforces its mission to deliver reliable and effective medical devices that contribute to the advancement of modern healthcare practices.
IRadimed stock FAQ
What is the IRadimed stock ticker symbol?
IRadimed Corporation trades on the NASDAQ under the ticker symbol IRMD.
What sector and industry is IRadimed in?
IRadimed Corporation is classified in the Healthcare sector, Medical Devices industry.
How many employees does IRadimed have?
IRadimed Corporation has about 166 full-time employees.
What were IRadimed's revenue and earnings last fiscal year?
IRadimed reported revenue of $83.8M and net income of $22.5M in fiscal 2025, with earnings per share of $1.92. Revenue grew 14.4% from the prior year.
Is IRadimed in the Russell 2000?
Yes. IRadimed Corporation (IRMD) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did IRadimed go public?
IRadimed stock began trading on July 16, 2014.
Russell 2000 Medical Devices stocks
All Russell 2000 →- AORTArtivion
- ATECAlphatec
- AXGNAxoGen
- BFLYButterfly Network
- CNMDCONMED
- ENOVEnovis
- ESTAEstablishment Labs
- GKOSGlaukos
- HAEHaemonetics
- IARTIntegra LifeSciences
- INSPInspire Medical Systems
- IRTCiRhythm
- ITGRInteger
- LIVNLivaNova
- NEOGNeogen
- NVCRNovoCure
- PRCTPROCEPT BioRobotics
- QDELQuidelOrtho
- SIBNSI-BONE
- TMDXTransMedics
- TNDMTandem Diabetes Care
- TXG10x Genomics
- UFPTUFP Technologies
- VREXVarex Imaging